FDA Approved: * May 11, 1989
Pharm Company: * WATSON LABS
Category: Antidepressant

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Amoxapine Overview

Amoxapine, sold under the brand name Asendin among others, is a tetracyclic antidepressant (TeCA). It is the N-demethylated metabolite of loxapine. Amoxapine first received marketing approval in the United States in 1992 (approximately 30 to 40 years after most of the other TCAs were introduced in the United States).[1] Contents 1 Medical uses 2 Contraindications 2.1 Lactation 3 Side effects 4 Overdose 5 Pharmacology 5.1 Pharmacodynamics 5.2 Pharmacokinetics 6 Society ...

Read more Amoxapine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Amoxapine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 100mg, 150mg, 25mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Amoxapine: (5 results)

Sorted by National Drug Code
  • 0591-5713 Amoxapine 25 mg Oral Tablet by Watson Laboratories, Inc.
  • 0591-5714 Amoxapine 50 mg Oral Tablet by Watson Laboratories, Inc.
  • 0591-5715 Amoxapine 100 mg Oral Tablet by Watson Laboratories, Inc.
  • 0591-5716 Amoxapine 150 mg Oral Tablet by Watson Laboratories, Inc.
  • 54868-2438 Amoxapine 50 mg Oral Tablet by Physicians Total Care, Inc.

Other drugs which contain Amoxapine or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 August 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA